Vincent Lisowski

2.8k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Vincent Lisowski is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Vincent Lisowski has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 31 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Vincent Lisowski's work include Synthesis and pharmacology of benzodiazepine derivatives (12 papers), Chemical Synthesis and Analysis (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Vincent Lisowski is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (12 papers), Chemical Synthesis and Analysis (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Vincent Lisowski collaborates with scholars based in France, United States and South Korea. Vincent Lisowski's co-authors include Jean Martínez, Patrick Vlieghe, Sylvain Rault, Nicolas Masurier, Ludovic T. Maillard, Patrick Dallemagne, Christophe Rochais, S. Rault, Cyril Fersing and Jean‐François Hernandez and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Vincent Lisowski

56 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic therapeutic peptides: science and market

2009 1.2k citations Patrick Vlieghe, Vincent Lisowski et al. Drug Discovery Today profile →

Peers

Countries citing papers authored by Vincent Lisowski

Since Specialization

Citations

This map shows the geographic impact of Vincent Lisowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lisowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lisowski more than expected).

Fields of papers citing papers by Vincent Lisowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lisowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lisowski. The network helps show where Vincent Lisowski may publish in the future.

Co-authorship network of co-authors of Vincent Lisowski

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lisowski. A scholar is included among the top collaborators of Vincent Lisowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lisowski. Vincent Lisowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Nadia Amanzougaghene, Sébastien Hutter, (unknown), Jean‐François Franetich, (unknown), Aurélie Malzert‐Fréon, Sophie Corvaisier, Nadine Azas, Patrice Vanelle, Pierre Verhaeghe, Nicolas Primas, Dominique Mazier, Nicolas Masurier, Vincent Lisowski	6
2	Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Sébastien Hutter, (unknown), Jean‐François Franetich, (unknown), Aurélie Malzert‐Fréon, Sophie Corvaisier, Marc Since, Nadine Azas, Patrice Vanelle, Pierre Verhaeghe, Nicolas Primas, Dominique Mazier, Nicolas Masurier, Vincent Lisowski	2
3	4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives 2022 ·Pharmaceuticals ·(unknown), (unknown), Nadia Amanzougaghene, Sébastien Hutter, Jean‐François Franetich, Nadine Azas, Patrice Vanelle, Pierre Verhaeghe, Nicolas Primas, Dominique Mazier, Nicolas Masurier, Vincent Lisowski	4
4	Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Sébastien Hutter, (unknown), Nadia Amanzougaghene, (unknown), Jean‐François Franetich, Sophie Corvaisier, Marc Since, Aurélie Malzert‐Fréon, Nicolas Masurier, Vincent Lisowski, Pierre Verhaeghe, Dominique Mazier, Nadine Azas, Patrice Vanelle, Nicolas Primas	5
5	Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment 2021 ·Pharmaceutics ·(unknown), (unknown), (unknown), Pascal Verdié, Audrey Davis, Sophie Corvaisier, Vincent Lisowski, Patrick Dallemagne, Anne‐Claire Groo, Aurélie Malzert‐Fréon	9
6	Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents 2021 ·Pharmaceuticals ·(unknown), Cyril Fersing, Nicolas Masurier, Vincent Lisowski	35
7	Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators 2021 ·EJNMMI Radiopharmacy and Chemistry ·Cyril Fersing, Emmanuel Deshayes, (unknown), (unknown), Vincent Lisowski, (unknown)	1
8	Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Cyril Fersing, Céline Gongora, Jean‐Pierre Pouget, Vincent Lisowski	7
9	Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation 2020 ·Frontiers in Chemistry ·Marion Peyressatre, (unknown), (unknown), Juan A. González‐Vera, Morgan Pellerano, Nicolas Masurier, Vincent Lisowski, May C. Morris	13
10	Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells 2016 ·European Journal of Medicinal Chemistry ·Virginie Bellet, (unknown), (unknown), Audrey Gallud, Vincent Lisowski, Ludovic T. Maillard, Marcel Garcia, Jean Martínez, Nicolas Masurier	17
11	Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7 2015 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Vincent Lisowski, (unknown), (unknown), Ludovic T. Maillard, Jean Martínez, Nicolas Masurier, Chahrazade El Amri	18
12	Thiazole‐Based γ‐Building Blocks as Reverse‐Turn Mimetic to Design a Gramicidin S Analogue: Conformational and Biological Evaluation 2014 ·Chemistry - A European Journal ·Baptiste Legrand, (unknown), Aurélien Lebrun, (unknown), Vincent Lisowski, Nicolas Masurier, Séverine Zirah, Young Kee Kang, Jean Martínez, Ludovic T. Maillard	38
13	Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity 2014 ·European Journal of Medicinal Chemistry ·Audrey Gallud, Ophélie Vaillant, Ludovic T. Maillard, (unknown), Joëlle Dubois, Marie Maynadier, Vincent Lisowski, Marcel Garcia, Jean Martínez, Nicolas Masurier	41
14	Helical Oligomers of Thiazole‐Based γ‐Amino Acids: Synthesis and Structural Studies 2013 ·Angewandte Chemie International Edition ·(unknown), Baptiste Legrand, Cheng Deng, Lubomir Vezenkov, Emmanuel Wenger, Claude Didierjean, Muriel Amblard, Marie‐Christine Averlant‐Petit, Nicolas Masurier, Vincent Lisowski, Jean Martínez, Ludovic T. Maillard	59
15	Further characterization of a putative serine protease contributing to the γ-secretase cleavage of β-amyloid precursor protein 2012 ·Bioorganic & Medicinal Chemistry ·Marine Peuchmaur, (unknown), Jean Sévalle, Vincent Lisowski, (unknown), (unknown), Jean Martínez, Frédéric Checler, Jean‐François Hernandez	4
16	Cyclic Peptides with a Diversely Substituted Guanidine Bridge: Solid‐Phase Synthesis and Structural Analysis 2011 ·Chemistry - A European Journal ·(unknown), L. Chiche, Abdallah Hamzé, André Aumelas, Vincent Lisowski, Dorothée Berthomieu, Jean Martínez, Jean‐François Hernandez	10
17	Synthetic therapeutic peptides: science and market breakdown → 2009 ·Drug Discovery Today ·Patrick Vlieghe, Vincent Lisowski, Jean Martínez, (unknown)	1188
18	Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent 2006 ·International Journal of Pharmaceutics ·Aurélie Malzert‐Fréon, Sandy Vrignaud, Patrick Saulnier, Vincent Lisowski, Jean‐Pierre Benoît, S. Rault	32
19	Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil 2005 ·European Journal of Medicinal Chemistry ·Ziad Omran, Thomas Cailly, (unknown), Jana Sopková‐de Oliveira Santos, (unknown), Vincent Lisowski, Frédéric Fabis, (unknown), Silvia Stiebing, (unknown), Michel Boulouard, François Dauphin, Patrick Dallemagne, Sylvain Rault	32
20	Synthesis of New Aromatic Pyrrolo[2,1- c] [1,4]benzodiazepines and Pyrrolo[1,2- a] thieno[3,2- e] [1,4]diazepines as Anti-tumoral Agents 2002 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Vincent Lisowski, Frédéric Fabis, Alain St. Pierre, Daniel‐Henri Caignard, Pierre Renard, Sylvain Rault	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact